Rituximab supply framework contract
Titre original de l'avis
Malta – Antineoplastic agents – CT2212/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF RITUXIMAB 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
Score d'opportunité
Pourquoi ce score ?
Opportunité
71 / 100
Complexité
42 / 100
Facteurs de risque
The notice text describes the contract as a framework contract, while structured data marks isFrameworkAgreement as fal...
Important procurement documents were available via URL but their extracted text was not provided, so technical, contrac...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Informations clés
- Pouvoir adjudicateur
- Department of Contracts
- Pays
- Malte
- CPV
- 33652100 - Antineoplastic agents
- Date limite
- Aug 04, 2026
- Valeur estimée
- EUR 1.4M
Aperçu
Moderate opportunityFaits clés
- EUR 1.4M estimated value
- Supplies contract
- 1 lot
- Supply of rituximab 10mg/ml concentrate for solution for infusion.
- Medical/antineoplastic pharmaceutical supplies for performance in Malta.
Afficher le résumé complet
Open supply tender in Malta for a framework contract to supply rituximab 10mg/ml concentrate for solution for infusion (CPV 33652100). One lot is shown. Estimated value is EUR 1,363,820.60. Electronic submission is required. Procurement documents are available via the e-tenders portal, but only the TED XML notice text was analyzed, not the full procurement documents.
Risques
The notice text describes the contract as a framework contract, while structured data marks isFrameworkAgreement as fal...
Important procurement documents were available via URL but their extracted text was not provided, so technical, contrac...
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Administrative
- Electronic submission is required.
- Submission deadline: 2026-08-04T07:30:00Z according to structured data; XML text shows EndTime 09:30:00+02:00 on the same date, which corresponds to the same moment in UTC.
- Language of notice/tender is English; XML notice also detects Maltese.
Critères d'attribution
Lot 1
Acheteur
Localisation
Floriana, MLT
Site web
Profil acheteur
Identifiant
MT25645419
Activité
General public services
Lots (1)
LOT-0001
Rituximab supply framework contract
Supply of rituximab 10mg/ml concentrate for solution for infusion in Malta. The lot is described as a framework contract in the notice, but the structured data flags isFrameworkAgreement as false, so there is an internal inconsistency. Value and scope are given at lot level.
EUR 1.4M
Valeur estimée
Localisation
Catégorie
Critères d'attribution
Date limite
Détails des critères
CT2212/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF RITUXIMAB 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
Note sur la valeur
Afficher les données TED originales
Titre original du lot
CT2212/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF RITUXIMAB 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
Description TED originale
CT2212/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF RITUXIMAB 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
Détails de la procédure
- Date de publication
- 30 Jun 2026
- Langues
- English
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 452456-2026
Documents (2)
Score d'opportunité
Pourquoi ce score ?
Opportunité
71 / 100
Complexité
42 / 100
Facteurs de risque
The notice text describes the contract as a framework contract, while structured data marks isFrameworkAgreement as fal...
Important procurement documents were available via URL but their extracted text was not provided, so technical, contrac...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications